These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17338432)

  • 21. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Held-Warmkessel J
    Oncol Nurs Forum; 2014 Sep; 41(5):551-3. PubMed ID: 25158661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine-associated thrombotic microangiopathy in a patient with lung cancer: A case report.
    Lai-Tiong F; Duval Y; Krabansky F
    Oncol Lett; 2017 Mar; 13(3):1201-1203. PubMed ID: 28454234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
    Katagiri D; Hinoshita F
    CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasculitis due to gemcitabine.
    Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
    Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
    Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
    Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer.
    Maestu I; Gómez-Aldaraví L; Torregrosa MD; Camps C; Llorca C; Bosch C; Gómez J; Giner V; Oltra A; Albert A
    Lung Cancer; 2003 Dec; 42(3):345-54. PubMed ID: 14644523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature.
    Mirza AS; Verma S; Fu L; Bassil C
    J Hematol; 2017 Sep; 6(2-3):52-58. PubMed ID: 32300393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.
    Facchini L; Lucchesi M; Stival A; Roperto RM; Melosi F; Materassi M; Farina S; Tintori V; de Martino M; Sardi I
    J Med Case Rep; 2017 Jul; 11(1):209. PubMed ID: 28747219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
    Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
    Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.
    Mir-Bonafé JM; Román-Curto C; Santos-Briz A; Cañueto J; Fernández-López E; Unamuno P
    J Cutan Pathol; 2012 Jul; 39(7):707-11. PubMed ID: 22612305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer.
    Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T
    Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed anemia and thrombocytopenia after treatment with gemcitabine.
    Malayeri R; Krajnik G; Ohler L; Pirker R
    J Natl Cancer Inst; 1997 Aug; 89(15):1164. PubMed ID: 9262256
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
    Tibaldi C; Ricci S; Russo F; Bernardini I; Galli L; Chioni A; Orlandini C; Grosso AM; Pegna AL; Fabbri A; Innocenti F; Ferrari K; Tognarini L; Conte PF; Falcone A;
    Lung Cancer; 2005 Apr; 48(1):121-7. PubMed ID: 15777979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].
    Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M
    Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
    Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L
    Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
    Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
    Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.
    Zhang X; Lu J; Xu J; Li H; Wang J; Qin Y; Ma P; Wei L; He J
    Respirology; 2013 Jan; 18(1):131-9. PubMed ID: 22882698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.